Twist Bioscience Co. (NASDAQ:TWST) Receives $42.50 Average PT from Brokerages

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has earned a consensus rating of “Buy” from the six research firms that are covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have covered the stock in the last […]

Related Keywords

United Kingdom ,William Banyai ,Emilym Leproust ,Robertw Baird ,Invesco Ltd ,United Kingdom Plc ,Twist Bioscience Co ,Twist Bioscience Corporation ,Artisan Partners Limited Partnership ,Nasdaq ,Barclays ,Norges Bank ,Investment Management ,Scotiabank ,Twist Bioscience ,Get Free Report ,Partners Limited Partnership ,Kingdom Plc ,Get Free ,Bioscience Corporation ,Twist Bioscience Daily ,